NCT06616441View on ClinicalTrials.gov

The Effect of Intraperitoneal Instillation of Bupivacaine on Postoperative Pain After Surgical Laparoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 15, 2024

Study Completion Date

September 15, 2024

Conditions
Post Operative Pain
Interventions
DRUG

Bupivacaine

Group (A) only will receive intra-peritoneal 40 ml bupivacaine 0.2%, after laparoscopic procedure before removing trocars.

Trial Locations (1)

Unknown

Faculty of Medicine, University of Alexandria, Alexandria

All Listed Sponsors
lead

El Shatby University Hospital for Obstetrics and Gynecology

OTHER

NCT06616441 - The Effect of Intraperitoneal Instillation of Bupivacaine on Postoperative Pain After Surgical Laparoscopy | Biotech Hunter | Biotech Hunter